Soluble cytokine receptors

Blood

Volumn 87, Issue 3, 1996, Pages 847-857

  Heaney, Mark L ^a   Golde, David W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR RECEPTOR; CYTOKINE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ERYTHROPOIETIN RECEPTOR; INTERFERON RECEPTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN RECEPTOR; MESSENGER RNA; NERVE GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RECEPTOR SUBUNIT; TUMOR NECROSIS FACTOR RECEPTOR;

ALLERGIC ENCEPHALITIS; ALTERNATIVE RNA SPLICING; CARBOXY TERMINAL SEQUENCE; DISEASE ACTIVITY; DNA SEQUENCE; GENE EXPRESSION; GENE STRUCTURE; GRAFT SURVIVAL; HUMAN; INFLAMMATION; LUNG FIBROSIS; NONHUMAN; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0030063533     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.3.847.bloodjournal873847     Document Type: Review

References (146)

1. Golde DW: The stem cell. Sci Am 265:86, 1991
2. Heaney ML, Golde DW: Soluble hormone receptors. Blood 82:1945, 1993
3. Davis S, Aldrich TH, Valenzuela DM, Wong V, Furth ME, Squinto SP, Yancopoulos GD: The receptor for ciliary neurotrophic factor. Science 253:59, 1991
4. Davis S, Aldrich TH, Ip NY, Stahl N, Scherer S, Farruggella T. DiStefano PS, Curtis R, Panayotatos N, Gascan H, Chevalier S, Yancopoulous GD: Released form of CNTF receptor a component as a soluble mediator of CNTF responses. Science 259:1736, 1993
5. Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK, Squires CH, Thompson RC, Vannice JL: A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 87:8331, 1990
6. Hwang C, Gatanaga M, Granger G, Gatanaga T: Mechanism of release of soluble forms of tumor necrosis factor/lymphotoxin receptors by phorbol myristate acetate-stimulated human THP-1 cells in vitro. J Immunol 151:5631, 1993
7. Symons JA, Duff GW: A soluble form of the interleukin-1 receptor produced by a human B cell line. FEBS Lett 272:133, 1990
8. Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL: Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135:3172, 1985
9. Rubin LA, Nelson DL. The soluble interleukin-2 receptor. Biology, function, and clinical application. Ann Intern Med 113:619, 1990
10. Downing JR, Roussel MF, Sherr CJ: Ligand and protein kinase C down-modulate the colony-stimulating factor 1 receptor by independent mechanisms. Mol Cell Biol 9:2890, 1989
11. Tiesman J, Hart CE: Identification of a soluble receptor for platelet-derived growth factor in cell-conditioned medium and human plasma. J Biol Chem 268:9621, 1993
12. Zupan AA, Johnson E Jr: Evidence for endocytosis-dependent proteolysis in the generation of soluble truncated nerve growth factor receptors by A875 human melanoma cells. J Biol Chem 266:15384, 1991
13. Barker PA, Miller FD, Large TH, Murphy RA: Generation of the truncated form of the nerve growth factor receptor by rat Schwann cells. Evidence for post-translational processing. J Biol Chem 266:19113, 1991
14. Heaney ML, Vera JC, Raines MA, Golde D: Membrane-associated and soluble granulocyte/macrophage-colony-stimulating factor receptor α subunits are independently regulated in HL-60 cells. Proc Natl Acad Sci USA 92:2365, 1995
15. Raines MA, Liu L, Quan SG, Joe V, DiPersio JF, Golde DW: Identification and molecular cloning of a soluble human granulocyte-macrophage colony-stimulating factor receptor. Proc Natl Acad Sci USA 88:8203, 1991
16. Nakagawa Y, Kosugi H, Miyajima A, Arai K-i, Yokata T: Structure of the gene encoding the α subunit of the human granulocyte-macrophage colony stimulating factor receptor. J Biol Chem 269:10905, 1994
17. Ashworth A, Kraft A: Cloning of a potentially soluble receptor for human GM-CSF. Nucleic Acids Res 18:7178, 1990
18. Hu X, Emanuel PD, Zuckerman KS: Cloning and sequencing of the cDNAs encoding two alternative splicing-derived variants of the alpha subunit of the granulocyte-macrophage colony-stimulating factor receptor. Biochim Biophys Acta 1223:306, 1994
19. Fukunaga R, Ishizaka-Ikeda E, Nagata S: Purification and characterization of the receptor for murine granulocyte colony-stimulating factor. J Biol Chem 265:14008, 1990
20. Mosley B, Beckmann MP: The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms. Cell 59:335, 1989
21. Sempowski GD, Beckmann MP, Derdak S, Phipps RP: Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 152:3606, 1994
22. Takaki S, Tominaga A, Hitoshi Y, Mita S, Sonada E, Yamaguchi N, Takatsu K: Molecular cloning and expression of the murine interleukin-5 receptor. EMBO J 9:4367, 1990
23. Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, Fiers W, Plactinck G: A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 66:1175, 1991
24. Tavernier J, Tuypens T, Plaetinck G, Verhee A, Fiers W, Devos R: Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit. Proc Natl Acad Sci USA 89:7041, 1992
25. Tuypens T, Plaetinck G, Baker E, Sutherland G, Brusselle G, Fiers W, Devos R, Tavernier J: Organization and chromosomal localization of the human interleukin 5 receptor alpha-chain gene. Eur Cytokine Netw 3:451, 1992
26. Goodwin RG, Friend D, Ziegler SF, Jerzy R, Falk BA, Gimpel S, Cosman D, Dower SK, March CJ, Namen AE, Park LS: Cloning of the human and murine interleukin-7 receptors: Demonstration of a soluble form and homology to a new receptor superfamily. Cell 60:941, 1990
27. Renauld JC, Druez C, Kermouni A, Houssiau F, Uyttenhove C, Van Roost E, Van Snick J: Expression cloning of the murine and human interleukin 9 receptor cDNAs. Proc Natl Acad Sci USA 89:5690, 1992
28. Layton MJ, Cross BA, Metcalf D, Ward LD, Simpson RJ, Nicola NA: A major binding protein for leukemia inhibitory factor in normal mouse serum: Identification as a soluble form of the cellular receptor. Proc Natl Acad Sci USA 89:8616, 1992
29. Tomida M, Yamamoto-Yamaguchi Y, Hozumi M: Pregnancy associated increase in rnRNA for soluble D-factor/LIF receptor in mouse liver. FEBS Lett 334:193, 1993
30. Tomida M, Yamamoto-Yamaguchi Y, Hozumi M: Three different cDNAs encoding mouse D-factor/LIF receptor. J Biochem 115:557, 1994
31. Gearing DP, Thut CJ, VandeBos T, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckmann MP: Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J 10:2839, 1991
32. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759, 1994
33. Cascino I, Fiucci G, Papoff G, Ruberti G: Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 154:2706, 1995
34. Flickinger TW, Maihle NJ, Kung HJ: An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation. Mol Cell Biol 12:883, 1992
35. Maihle NJ, Flickinger TW, Raines MA, Sanders ML, Kung H-J: Native avian c-erbB gene expresses a secreted protein product corresponding to the ligand-binding domain of the receptor. Proc Natl Acad Sci USA 88:1825, 1991
36. Petch LA, Harris J, Raymond VW, Blasband A, Lee DC, Earp HS: A truncated, secreted form of the epidermal growth factor receptor is encoded by an alternatively spliced transcript in normal rat tissue. Mol Cell Biol 10:2973, 1990
37. Abramovich C, Ratovitski E, Lundgren E, Revel M: Identification of mRNAs encoding two different soluble forms of the human interferon alpha-receptor. FEBS Lett 338:295, 1994
38. Novick D, Cohen B, Rubinstein M: The human interferon alpha/beta receptor: Characterization and molecular cloning Cell 77:391, 1994
39. Vigon I, Florindo C, Fichelson S, Guenet JL, Mattei MG, Souyri M, Cosman D, Gisselbrecht S: Characterization of the murine Mp1 proto-oncogene, a member of the hematopoietic cytokine receptor family: Molecular cloning, chromosomal location and evidence for a function in cell growth. Oncogene 8:2607, 1993
40. Todokaro K, Kuramochi S, Nagasawa T, Abe T, Ikawa Y: Isolation of a cDNA encoding a potential soluble receptor for human erythropoietin. Gene 106:283, 1991
41. Barron C, Migliaccio AR, Migliaccio G, Jiang Y, Adamson JW, Ottolenghi S: Alternatively spliced mRNAs encoding soluble isoforms of the erythropoietin receptor in murine cell lines and bone marrow. Gene 147:263, 1994
42. Robb RJ, Kutny RM: Structure-function relationships for the IL 2-receptor system. J Immunol 139:855, 1987
43. Nakamura Y, Komatsu N, Nakauchi H: A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science 257:1138, 1992
44. Fanslow WC, Spriggs MK, Rauch CT, Clifford KN, Macduff BM, Ziegler SF, Schooley KA, Mohler KM, March CJ, Armitage RJ: Identification of a distinct low-affinity receptor for human interleukin-4 on pre-B cells. Blood 81:2998, 1993
45. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, Kishimoto T, Suda T: Soluble mterleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 90:11924, 1993
46. Novick D, Engelmann H, Revel M, Leitner O, Rubinstein M: Monoclonal antibodies to the soluble human IL-6 receptor: Affinity purification, ELISA, and inhibition of ligand binding. Hybridoma 10:137, 1991
47. Hanneken A, Ying W, Ling N, Baird A: Identification of soluble forms of the fibroblast growth factor receptor in blood. Proc Natl Acad Sci USA 91:9170, 1994
48. Basu A, Raghunath M, Bishayee S, Das M: Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: Role for interreceptor interaction in kinase regulation. Mol Cell Biol 9:671, 1989
49. Sotiropoulos A, Goujon L, Simonin G, Kelly PA, Postel-Vinay MC, Finidori J: Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor. Endocrinology 132:1863, 1993
50. Baumbach WR, Horner DL, Logan JS: The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes Dev 3:1199, 1989
51. Vandenbark GR, deCastro CM, Taylor H, Dew-Knight S, Kaufman RE: Cloning and structural analysis of the human c-kit gene. Oncogene 7:1259, 1992
52. Wypych J, Bennett LG, Schwartz MG, Clogston CL, Lu HS, Broudy VC, Bartley TD, Parker VP, Langley KE: Soluble kit receptor in human serum. Blood 85:66, 1995
53. Mullberg J, Schooltink H, Stoyan T, Gunther M, Graeve L, Buse G, Mackiewicz A, Heinrich PC. Rose-John S: The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 23:473, 1993
54. Mullberg J, Oberthur W, Lottspeich F, Mehl E, Dittrich E, Graeve L, Heinrich PC, Rose-John S: The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. J Immunol 152:4958, 1994
55. Lust JA, Donovan KA, Kline MP, Greipp PR, Kyle RA, Maihle NJ: Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4:96, 1992
56. Horiuchi S, Koyanagi Y, Zhou Y, Miyamoto H, Tanaka Y, Waki M, Matsumoto A, Yamamoto M, Yamamoto N: Soluble interleukin-6 receptors released from T cell or granulocyte/macrophagc cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur J Immunol 24:1945, 1994
57. Trinchieri G: Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008, 1994
58. Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick RM, Kelleher K, Herrmann SH, Clark SC, Azzoni L, Chan SH, Trinchieri G, Perussia B: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 146:3074, 1991
59. Gearing DP, Cosman D: Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell 66:9, 1991
60. Chilton PM, Fernandez-Botran R: Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4. J Immunol 151:5907, 1993
61. Bjornberg F, Lantz M, Olsson I, Gullberg U: Mechanisms involved in the processing of the p55 and the p75 tumor necrosis factor (TNF) receptors to soluble receptor forms. Lymphokine Cytokine Res 13:203, 1994
62. Lantz M, Bjornberg F, Olsson I, Richter J: Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms. J Immunol 152:1362, 1994
63. Porteu F, Hieblot C: Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. J Biol Chem 269:2834, 1994
64. Higuchi M, Aggarwal BB: TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J Immunol 152:3550, 1994
65. Ahn J, Johnstone RM: Origin of a soluble truncated transferrin receptor. Blood 81:2442, 1993
66. Cook JD, Skikne BS, Baynes RD: Serum transferrin receptor. Annu Rev Med 44:63, 1993
67. Herington AC, Ymer S, Stevenson J: Identification and characterization of specific binding proteins for growth hormone in normal human sera. J Clin Invest 77:1817, 1986
68. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI: Growth hormone receptor and serum binding protein: Purification, cloning and expression. Nature 330:537, 1987
69. Baumann G, Stolar MW, Amburn K, Barsano CP, DeVries BC: A specific growth hormone-binding protein in human plasma: Initial characterization. J Clin Endocrinol Metab 62:134, 1986
70. Baumann G, Shaw MA, Buchanan TA: In vivo kinetics of a covalent growth hormone-binding protein complex. Metabolism 38:330, 1989
71. Veldhuis JD, Johnson ML, Faunt LM, Mercado M, Baumann G: Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. J Clin Invest 91:629, 1993
72. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323, 1992
73. Carter A, Haddad N, Draxler I, Tatarsky I: Effects of soluble interleukin-1 receptor and tumor-necrosis factor receptor, respectively, on the IL-1- and TNF-alpha-induced DNA synthesis of acute myeloblastic leukemia blasts in vitro. Eur J Haematol 53:38, 1994
74. Sato TA, Widmer MB, Finkelman FD, Madani H, Jacobs CA, Grabstein KH, Maliszewski CR: Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J Immunol 150:2717, 1993
75. Fernandez-Botran R, Vitetta ES: Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins. J Exp Med 174:673, 1991
76. Arend WP: Interleukin-1 receptor antagonist. Adv Immunol 54:167, 1993
77. Arend WP, Malyak M, Smith M Jr, Whisenand TD, Slack JL, Sims JE, Giri JG, Dower SK: Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol 153:4766, 1994
78. Svenson M, Hansen MB, Heegaard P, Abell K, Bendtzen K: Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I. Cytokine 5:427, 1993
79. DiPersio JF, Hedvat C, Ford CF, Golde DW, Gasson JC: Characterization of the soluble human granulocyte-macrophage colony-stimulating factor receptor complex. J Biol Chem 266:279, 1991
80. Metcalf D, Nicola NA, Gearing DP, Gough NM: Low-affinity placenta-derived receptors for human granulocyte-macrophage colony-stimulating factor can deliver a proliferative signal to murine hematopoietic cells. Proc Natl Acad Sci USA 87:4670, 1990
81. Baldwin GC, Golde DW, Widhopf GF, Economou J, Gasson JC: Identification and characterization of a low-affinity granulocyte-macrophage colony-stimulating factor receptor on primary and cultured human melanoma cells. Blood 78:609, 1991
82. Kitamura T, Sato N, Arai K-i, Miyajima A: Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors. Cell 66:1165, 1991
83. Hayashida K, Kitamura T, Gorman DM, Arai K-i, Yokota T, Miyajima A: Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): Reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA 87:9655, 1990
84. Chiba S, Shibuya K, Piao Y-F, Tojo A, Sasaki N, Matsuki S, Miyagawa K, Miyazono K, Takaku F: Identification and cellular distribution of distinct proteins forming human GM-CSF receptor. Cell Regul 1:327, 1990
85. Park LS, Martin U, Sorensen R, Luhr S, Morrissey P, Cosman D, Larsen A: Cloning of the low-affinity murine granulocyte-macrophage colony-stimulating factor receptor and reconstitution of a high-affinity receptor complex. Proc Natl Acad Sci USA 89:4295, 1992
86. Taniguchi T: Cytokine signalling through nonreceptor protein tyrosine kinases. Science 268:251, 1995
87. Devos R, Guisez Y, Cornelis S, Verhee A, Van der Heyden J, Manneberg M, Lahm HW, Fiers W, Tavernier J, Plaetinck G: Recombinant soluble human interleukin-5 (ML-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5. J Biol Chem 268:6581, 1993
88. Brown C, Beaudry P, Laing TD, Shoemaker S, Kaushansky K: In vitro characterization of the human recombinant soluble granulocyte-macrophage colony-stimulating factor receptor. Blood 85:1488, 1995
89. Ding DX-H, Rivas CI, Heaney ML, Raines MA, Vera JC, Golde DW: The α subunit of the human granulocyte-macrophage colony-stimulating factor receptor signals for glucose transport via a phosphorylation-independent pathway. Proc Natl Acad Sci USA 91:2537, 1994
90. Spielholz C, Heaney ML, Morrison ME, Houghton AN, Vera JC, Golde DW: Granulocyte-macrophage colony-stimulating factor signals for increased glucose uptake in human melanoma cells. Blood 85:973, 1995
91. Nicola NA: Hematopoietic cell growth factors and their receptors Annu Rev Biochem 58:45, 1989
92. Gasson JC: Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77:1131, 1991
93. Tsuruoka N, Yamashiro K, Tsujimoto M: Purification of soluble murine interleukin 5 (IL-5) receptor alpha expressed in Chinese hamster ovary cells and its action as an IL-5 antagonist. Arch Biochem Biophys 307:133, 1993
94. Williams WV, VonFeldt JM, Rosenbaum H, Ugen KE, Weiner DB: Molecular cloning of a soluble form of the granulocyte-macrophage colony-stimulating factor receptor alpha chain from a myelomonocytic cell line. Expression, biologic activity, and preliminary analysis of transcript distribution. Arthritis Rheum 37:1468, 1994
95. Kishimoto T, Akira S, Taga T: Interleukin-6 and its receptor: A paradigm for cytokines. Science 258:593, 1992
96. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T: Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:573, 1989
97. Ip NY, Nye SH, Boulton TG, Davis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ, Stahl N, Yancopoulos GD: CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69:1121, 1992
98. Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B, Zeigler SF, Cosman D: The IL-6 signal transducer, gp130: An oncostatin M receptor and affinity converter for the LIF receptor. Science 255:1434, 1992
99. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobauashi M, Young D, Nickbarg E, Chizzonite R, Wolf SF, Trinchieri G: Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387, 1992
100. Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan Y-CE, Hakami J: Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 154:116, 1995
101. Gillessen S, Carvajal D, Ling P, Podlaski FJ, Stremlo DL, Familletti PC, Gubler U, Presky DH, Stern AS, Gately MK: Mouse interleukin-12 (IL-12) p40 homodimer: A potent IL-12 antagonist. Eur J Immunol 25:200, 1995
102. Narazaki M, Yasukawa K, Saito T, Ohsugi Y, Fukui H, Koishihara Y, Yancopoulos GD, Taga T, Kishimoto T: Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 82:1120, 1993
103. Yasukawa K, Futatsugi K, Saito T, Yawata H, Narazaki M, Suzuki H, Taga T, Kishimoto T: Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. Immunol Lett 31:123, 1992
104. Mullberg J, Dittrich E, Graeve L, Gerhartz C, Yasukawa K, Taga T, Kishimoto T, Heinrich PC, Rose-John S: Differential shedding of the two subunits of the inlerleukin-6 receptor. FEBS Lett 332:174, 1993
105. Blum A, Sclarovsky S, Rehavia E, Shohat B: Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction. Am Heart J 127:1226, 1994
106. Hashimoto S, Amemiya E, Tomita Y, Kobatashi T, Arai K, Yamaguchi M, Horie T: Elevation of soluble IL-2 receptor and IL-4, and nonelevation of IFN-gamma in sera from patients with allergic asthma. Ann Allergy 71:455, 1993
107. Brown PH, Crompton GK, Greening AP: Proinflammatory cytokines in acute asthma. Lancet 338:590, 1991
108. Cohen-Kaminsky S, Jacques Y, Aime C, Safar D, Morel E, Berrih-Aknin S: Follow-up of soluble interleukin-2 receptor levels after thymectomy in patients with myasthenia gravis. Clin Immunol Immunopathol 62:190, 1992
109. Symons JA, Wood NC, Di Giovone FS, Duff GW: Soluble IL-2 receptor in rheumatoid arthritis. J Immunol 141:2612, 1988
110. Fawcett PT, Rose CD, Proujansky R, Gibney KM, Molloy DM, Doughty RA: Serial measurement of soluble interleukin 2 receptor levels: An early indicator of treatment response for Lyme disease. J Rheum 20:996, 1993
111. Barral-Netto M, Barral A, Santos SB, Carvalho EM, Badaro R, Rocha H, Reed SG, Johnson W Jr: Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. J Immunol 147:281, 1991
112. Kamihira S, Atogami S, Sohda H, Momita S, Yamada Y, Tomonaga M: Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer 73:2753, 1994
113. Ambrosetti A, Semenzato G, Prior M, Chilosi M, Vinante F, Vincenzi C, Zanotti R, Trentin L, Porteuse A, Menestrina F, Perona G, Agostini C, Todeschini G, Pizzolo G: Serum levels of soluble interleukin-2 receptor in hairy cell leukemia: A reliable marker of neoplastic bulk. Br J Haemalol 73:181, 1989
114. Lauria F, Benfenati D, Raspadori D, Rondelli D, Zinzani PL, Tura S: High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine. Leuk Lymphoma 11:399, 1993
115. Chiliosi M, Semenzato G, Cetto G, Ambrosetti A, Fiore-Donati L, Perona G, Berton G, Lestani M, Scarpa A, Agostini C, Trentin L, Zambello R, Masciarelli M, Dazzi F, Vinante F, Caligaris-Cappio F, Pizzolo G: Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: Relationship with the effect of recombinant α-interferon therapy on clinical parameters and natural killer in vitro activity. Blood 70:1530, 1987
116. Gause A, Roschansky V, Tschiersch A, Smith K, Hasenclever D, Schmits R, Diehl V, Pfreundschuh M: Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma. Ann Oncol 2:43, 1991
117. Musolino C, Di Cesare E, Alonci A, Allegra A, Orlando A, Grosso P, Squadrito G: Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia. Acta Haematol 85:57, 1991
118. Berghella AM, Pellegrini P, Piancatelli D, Maccarone D, Del Beato T, Giubilei D, Pomidori A, Adorno D, Casciani CU: Progression mechanisms in colon cancer: Soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 prohferative response and tumour stage correlations. Cancer Immunol Immunother 38:160, 1994
119. Sharma S, Saha K, Shinghal RN, Malik GB: Serum soluble interleukin-2 (IL-2) receptor levels in women with breast carcinoma and its correlation with IL-2 receptor expression on blood lymphocytes and lymphocytic infiltration within the tumour. Cancer Immunol Immunother 33:198, 1991
120. Barton DP, Blanchard DK, Michelini-Norris B, Nicosia SV, Cavanagh D, Djeu JY: High serum and ascitic soluble interleukin-2 receptor alpha levels in advanced epithelial ovarian cancer. Blood 81:424, 1993
121. Barton DP, Blanchard DK, Wells AF, Nicosia SV, Roberts WS, Cavanagh D, Djeu JY: Expression of interleukin-2 receptor alpha (IL-2R alpha) mRNA and protein in advanced epithelial ovarian cancer. Anticancer Res 14:761, 1994
122. Nassberger L, Traskman-Bendz L: Increased soluble interleukin-2 receptor concentrations in suicide attempters. Acta Psych Scand 88:48, 1993
123. Michihiko S, Yamamoto N, Shinozaki F, Shimada K, Soma G-I, Kobayashi N: Augmentation of in-vitro HIV replication in peripheral blood mononuclear cells of AIDS and ARC patients by tumor necrosis factor. Lancet 1:1206, 1989
124. Folks TM, Clouse KA, Justement J, Rabson S, Duh E, Kehrl JH, Fauci AS: Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci USA 86:2365, 1989
125. Kitano K, Rivas C, Baldwin GC, Vera JC, Golde DW: Tumor necrosis factor-dependent production of human immunodeficiency virus1 in chronically infected HL-60 cells. Blood 82:2742, 1993
126. Kalinkovich A, Engelmann H, Harpaz N, Burstein R, Barak V, Kalickman I, Wallach D, Bentwich Z: Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin Exp Immunol 89:351, 1992
127. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF: Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 89:4845, 1992
128. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D: Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 54:1, 1995
129. Froon AH, Bemelmans MH, Greve JW, van der Linden CJ, Buurman WA: Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: Correlation with plasma creatinine values. Crit Care Med 22:803, 1994
130. Rogy MA, Coyle SM, Oldenburg HS, Rock CS, Barie PS, Van Zee KJ, Smith CG, Moldawer LL, Lowry SF: Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J Am Coll Surg 178:132, 1994
131. Spinas GA, Keller U, Brockhaus M: Release of soluble receptors for tumor necrosib factor (TNF) in relation to circulating TNF during experimental endotoxemia. J Clin Invest 90:533, 1992
132. Girardin E, Roux-Lombard P, Grau GE, Suter P, Gallati H, Dayer JM: Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group. Immunology 76:20, 1992
133. Klein B, Zhang X-G, Lu Z-Y, Bataille R: Interleukin-6 in human multiple myeloma. Blood 85:863, 1995
134. Gaillard JP, Bataille R, Brailly H, Zuber C, Yasukawa K, Attal M, Maruo N, Taga T, Kishimoto T, Klein B: Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol 23.820, 1993
135. Hale KK, Smith CG, Baker SL, Vanderslice RW, Squires CH, Gleason TM, Tucker KK, Kohno T, Russell DA: Multifunctional regulation of the biological effects of TNF-α by the soluble type I and type II TNF receptors. Cytokine 7:26, 1995
136. Abraham E, Coulson WF, Schwartz MD, Allbee J: Effects of therapy with soluble tumour necrosis factor receptor fusion protein on pulmonary cytokine expression and lung injury following haemorrhage and resuscitation. Clin Exp Immunol 98:29, 1994
137. Piguet PF, Vesin C: Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Resp J 7:515, 1994
138. Ashkenazi A, Marsters SA, Capon DJ, Chamow SM, Figari IS, Pennica D, Goeddel DV, Palladino MA, Smith DH: Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci USA 88:10535, 1991
139. Howard OM, Clouse KA, Smith C, Goodwin RG, Farrar WL: Soluble tumor necrosis factor receptor: Inhibition of human immunodeficiency virus activation. Proc Natl Acad Sci USA 90:2335, 1993
140. Jacobs CA, Baker PE, Roux ER, Picha KS, Toivola B, Waugh S, Kennedy MK: Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor. J Immunol 146:2983, 1991
141. Maliszewski CR, Morrissey PJ, Fanslow WC, Sato TA, Willis C, Davison B: Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor. Cell Immunol 143:434, 1992
142. Fanslow WC, Clifford KN, Park LS, Rubin AS, Voice RF, Beckmann MP, Widmer MB: Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. J Immunol 147:535, 1991
143. Broudy VC, Kovach NL, Bennett LG, Lin N, Jacobsen FW, Kidd PG: Human umbilical vein endothelial cells display high-affinity c-kit receptors and produce a soluble form of the c-kit receptor. Blood 83:2145, 1994
144. Anderson DL, Lyman SD, Baird A, Wignall JM, Eisenman J, Rauch C, March CJ, Boswell HS, Gimpel SD, Cosman D, Williams DE: Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63:235, 1990
145. Flanagan JG, Leder P: The kit ligand: A cell surface molecule altered in steel mutant fibroblasts. Cell 63:185, 1990
146. d mutant. Cell 64:1025, 1991